Focal therapy of localised prostate cancer by vascular targeted photodynamic therapy with WST-11 (TOOKAD® Soluble)

European Urological Review

Volumn 7, Issue 2, 2012, Pages 106-108

  Coleman, Jonathan ^a   Scherz, Avigdor ^b  

^a Division of Urology   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Focal therapy; Photodynamic therapy; Prostate; Prostate cancer; Reactive nitrogen species; Reactive oxygen species; TOOKAD

Indexed keywords

EID: 84871835498     PISSN: 17583829     EISSN: 1758406X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mazor O, Brandis A, Plaks V, et al., WST11, a novel watersoluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model, Photochem Photobiol, 2005;81(2):342-51.
2. Fabre MA, Fuseau E, Ficheux H, Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modelling, J Pharm Sci, 2007;96(12):3444-56.
3. Berdugo M, Bejjani RA, Valamanesh F, et al., Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes, Invest Ophthalmol Vis Sci, 2008;49(4):1633-44.
4. Ashur I, Goldschmidt R, Pinkas I, et al., Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin, J Phys Chem A, 2009;113(28):8027-37.
5. Vakrat-Haglili Y, Weiner L, Brumfeld V, et al., The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide, J Am Chem Soc, 2005;127(17):6487-97.
6. Gal Y, Madar-Balakirski N, Goldshmidt R, et al., Light induced oxidative/nitrosative stress offers compelling cancer therapy, (submitted).
7. Gross S, Gilead A, Scherz A, et al., Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI, Nat Med, 2003;9(10):1327-31.
8. Tempel-Brami C, Pinkas I, Scherz A, Salomon Y, Detection of light images by simple tissues as visualized by photosensitized magnetic resonance imaging, PLoS One, 2007;2(11):e1191.
9. Madar-Balakirski N, Tempel-Brami C, Kalchenko V, et al., Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with TOOKAD, PLoS One, 5(4): e10282.
10. Preise D, Oren R, Glinert I, et al., Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity, Cancer Immunol Immunother, 2009;58(1):71-84.
11. Preise D, Scherz A, Salomon Y, Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP), Photochem Photobiol Sci, 2011;10(5):681-8.
12. Betrouni N, Lopes R, Puech P, et al., A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD Soluble WST11, Phys Med Biol, 2011;56(15):4771-83.
13. Chevalier S, Anidjar M, Scarlata E, et al., Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate, J Urol, 2011;186(1):302-9.
14. Davidson SR, Weersink RA, Haider MA, et al., Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer, Phys Med Biol, 2009;54(8):2293-313.
15. Kimm S, Tarin T, Zhao P, et al., Optimizing array-based delivery of photodynamic therapy to solid organs in a large animal model, Journal of Urology, 2012;187, e346.
16. Tarin T, Kimm S, Zhao P, et al., Photothermal effect in vascular targeted photodynamic therapy, Journal of Urology, 2012;187, e609.
17. Trachtenberg J, Bogaards A, Weersink RA, et al., Vascular targeted photodynamic therapy with palladiumbacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response, J Urol, 2007;178(5):1974-9; discussion 1979.
18. Weersink RA, Forbes J, Bisland S, et al., Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients, Photochem Photobiol, 2005;81(1):106-13.
19. Haider MA, Davidson SR, Kale AV, et al., Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide, Radiology, 2007;244(1):196-204.
20. Chen Q, Huang Z, Luck D, et al., Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers, Photochem Photobiol, 2002;76(4):438-45.
21. Huang Z, Chen Q, Trncic N, et al., Effects of Pdbacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation, Radiat Res, 2004;161(6):723-31.
22. Trachtenberg J, Weersink RA, Davidson SR, et al., Vasculartargeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses, BJU Int, 2008;102(5):556-62.
23. Azzouzi AR, TOOKAD® Soluble, Vascular Targeted Phototherapy, Results of Phase II Studies, Presented at: 4th International Symposium on Focal Therapy and Imaging, 2011. Available at: www.focaltherapy.org/2011/Presentation/26-6.2_Azzouzi.pdf (Accessed 31 October 2012).
24. Azzouzi AR, Barret E, Villers A, et al., Results of TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Low Risk Localized Prostate Cancer (PCM201/PCM203), Eur Urol Suppl, 2011;10:54.
25. Azzouzi A, Barret E, Villers A, et al., Results of TOOKAD® Soluble Vascular Targeted Photodynamic Therapy (VTP) for Lor Risk Localized Prostate Cancer (PCM203), Journal of Urology, 2011;185,e718-9.
26. Arumainayagam N, Moore CM, Mosse CA, et al., TOOKAD Soluble (WST-11) second generation vascular targeted photodynamic therapy (VTP) for prostate cancer: Safety and feasibility, British Journal of Surgery, 2011;98:E10.
27. Moore CM, Emberton M, Bown SG, Photodynamic Therapy for Prostate Cancer-An Emerging Approach for Organ- Confined Disease, Lasers Surg Med, 2011;43(7):768-75.
28. Moore CM, Pendse D, Emberton M, Photodynamic therapy for prostate cancer-a review of current status and future promise, Nat Clin Pract Urol, 2009;6(1):18-30.
29. Eggener SE, Coleman JA, Focal treatment of prostate cancer with vascular-targeted photodynamic therapy, Scientific World Journal, 2008;8:963-73.